| Document Date: 2014-03-11 14:25:55
Open Document File Size: 183,51 KBShare Result on Facebook
Company Dose Modifications Management / Allos Therapeutics Inc / Alteon Inc. / / Event Product Issues / FDA Phase / Product Recall / / IndustryTerm yellow solution / clear yellow solution / mL solution / chemical name / non-pyrogenic clear yellow aqueous parenteral solution / aqueous solutions / transporter systems / drug products / / MedicalCondition lymphoma / Dermatologic Reactions Toxic epidermal necrolysis / Leukopenia / mucosal inflammation / nausea / Stomatitis / Thrombocytopenia / breast cancer resistance protein / toxic epidermal necrolysis / fatigue / febrile neutropenia / end stage renal disease undergoing dialysis / refractory peripheral T-cell lymphoma / Mucositis FOLOTYN / Tachycardia / Diarrhea / end stage renal disease / Constipation / Pruritus / Back pain / respiratory tract infection / sepsis / tumor / Abdominal pain / Epistaxis / cardiopulmonary arrest / end-stage renal disease undergoing dialysis / dyspnea / Carcinogenesis / 19b Nausea / ESRD / progressive disease / neutropenia / Tumor Lysis Syndrome / Mucositis / fever / pain / Vomiting / concomitant disease / Tumor Lysis Syndrome FOLOTYN / Cough / Hypokalemia / Rash / anemia / lymphoma clinical trials / pancytopenia / dehydration / / MedicalTreatment drug therapy / dialysis / / Organization National Cancer Institute / Per National Cancer Institute / DOSAGE AND ADMINISTRATION / FDA / / / Position General / treating physician / / Product probenecid / Sodium Chloride / Subsequent vitamin B12 injections / etoposide / folic acid / dose / CYP450 / Renal Function / / Technology Pharmacokinetics / dialysis / / URL www.fda.gov/medwatch / www.FOLOTYN.com / /
SocialTag |
Microsoft Word - draft-pi-clean.doc